Clinical Trial Update: The Analgesic Efficacy of Δ9-THC (Namisol®) in Patients With Persistent Postsurgical Abdominal Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Namisol (Delta-9-tetrahydrocannabinol) for analgesia in persistent postsurgical abdominal pain completed (NCT01562483).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Pain
• Pain
• Postoperative Pain

Drugs mentioned

• Namisol

Snippet

Sponsor: Radboud University Medical Center | Conditions: Postsurgical Pain, Abdominal Pain | Phase 2 | Status: COMPLETED